Higher levels of antimitochondrial antibodies in patients with systemic lupus erythematosus are tied to a higher risk for ...

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315) and Acepodia (6976:TT), today announced ...

Pathogens can create sticky situations. When microbes invade the body to cause an infection, often one of their first lines ...

Nona Biosciences ("Nona"), a global biotechnology company advancing biologics discovery through innovative technology ...

Researchers have developed a new class of antibodies that amplify the immune system’s ability to fight cancer. By clustering ...

Given the FDA’s decision to initiate the removal of boxed warning labels from hormone therapy products, it may be prescribed ...

Many patients endure hours-long infusions because antibody doses can exceed 100 milliliters, far beyond subcutaneous limits ...

After unsheathing just a few months ago, Ollin Biosciences’ next-gen bispecific antibody cleared more disease faster than ...

The company’s first-in-class and potential best-in-class therapeutics promise to be both effective and organ-protective and ...

Pathogens can create sticky situations. When microbes invade the body to cause an infection, often one of their first lines ...

First patient dosed in Phase 2 ASPEN-09-Breast trial evaluating evorpacept in combination with trastuzumab and physician’s ...

Researchers at the University of Southampton have developed a promising new way to bolster the body's immune system response to cancer.